Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 17. Отображено 17.
29-06-2011 дата публикации

HIV composite multi-epitope DNA vaccine and application thereof

Номер: CN0101579528B
Принадлежит:

The invention discloses an HIV composite multi-epitope DNA vaccine which takes HIV-1 capsid protein p24 as a vector backbone molecule and ER signal peptide as a homing sequence, and contains twenty-six highly conservative immunodominant epitopes in an HIV genome; wherein, the HIV composite multi-epitope DNA vaccine comprises twenty-nine epitopes which are three neutralizing antibody epitopes, twenty-three CTL epitopes, one HIV-1 isolate common antibody epitope, one MHC nonrestrictive T helper lymphocyte epitope and one spasmotoxin B cell epitope. The vaccine can be used for vaccination of healthy people and immunization therapy of people who are infected by AIDS virus, thus having double effects of prevention and treatment.

Подробнее
11-01-2012 дата публикации

Double-specificity anti-tumor recombinant adenovirus and construction method and application thereof

Номер: CN0101864452B
Принадлежит:

The invention provides a double-specificity anti-tumor recombinant adenovirus. The recombinant adenovirus comprises an adenovirus vector and expression boxes introduced therein; the replication of the adenovirus vector depends on gene mutation; and the expression boxes comprise an expression box consisting of tumor specific promoters and E1a genes and an expression box consisting of eukaryotic promoters and Apoptin genes. The invention also provides a construction mode of the double-specificity anti-tumor recombinant adenovirus and tumor treatment medicament application thereof. The recombinant adenovirus of the invention has double specificities of tumor specific replication and tumor specific killing, can be used for preparing medicaments for treating various tumors and medicaments for preventing tumor recurrence after operation, and meanwhile can be used with any medicament or used as a medicament combined with surgical therapy, radiotherapy and chemotherapy.

Подробнее
18-07-2023 дата публикации

Application of SR-717 agonist as novel coronavirus recombinant protein vaccine adjuvant

Номер: CN116440262A
Принадлежит:

The invention relates to an application of an SR-717 agonist as a novel coronavirus recombinant protein vaccine adjuvant. The SR-717 agonist is used as the novel coronavirus recombinant protein vaccine adjuvant for preparing the novel coronavirus recombinant protein vaccine, can improve the immune effect of the vaccine and induce strong body fluid and cell immune response, has good immunogenicity, and can be applied to development of the novel coronavirus vaccine and preparation of a neutralizing antibody.

Подробнее
05-05-2010 дата публикации

Gene chip for detecting influenza A virus and preparation method and application thereof

Номер: CN0101701266A
Принадлежит:

The invention relates to a gene chip for typing influenza A virus, a preparation method thereof, a detection method and a detection kit, wherein the gene chip comprises a solid phase carrier and an oligonucleotide probe which is fixed on the solid phase carrier and contains DNA segments selected from one or more genes of HA, NA and/or M of the influenza A virus. The gene chip of the invention has very high sensitivity and specificity, can be used for simultaneously detecting a plurality of groups of influenza A virus genes and identifying groups by adopting a multiple PCR amplification mode, has wide application prospects, can identify the specific serotype, has efficient and quick detection and analysis methods, and can be applied to the fields of life science, medical testing, food safety, environmental surveillance, import and export inspection and quarantine, bioterrorism prevention, epidemiological surveillance, and the like.

Подробнее
30-01-2008 дата публикации

PRRSV and PCV-2bivalent recombinant fowl pox virus disease live vector vaccines

Номер: CN0101112621A
Принадлежит:

The present invention relates to a PRRSV and PCV-2 bivalent recombinant fowlpox live vector vaccine, which pertains to the field of biotechnology. The present invention aims at providing the PRRSV and PCV-2 bivalent recombinant fowlpox live vector vaccine which has ORF5, ORF3 genes to express the structural glycoprotein of the PRRSV and ORF2 gene to express PCV-2 nucleocapsid protein and can be used as the live vector vaccine for the prevention of PRRS and PCV-2 infection in our country. The present invention constructs the pMD18T-ORF2, pMD18T-ORF5 and pMD18T-ORF3 plasmids, the plasmids are inserted to the downstream of the compound promoter ATI-P7.5 multiplied by 20 of the fowlpox virus expression vector pUTAL, at the same time, the ORF2 gene of the PCV2 are inserted to the downstream of the linking promoter P7.5 multiplied by 16, and the present invention further constructs the recombinant fowlpox virus gene transfer plasmid pUTAL-ORF2-ORF5-ORF3 which contains the ORF3-ORF3 gene of the ...

Подробнее
18-07-2023 дата публикации

Application of MK-571 as influenza virus mRNA vaccine adjuvant

Номер: CN116440261A
Принадлежит:

The invention relates to an application of MK-571 as an influenza virus mRNA (messenger Ribonucleic Acid) vaccine adjuvant. According to the invention, the MK-571 is applied to the influenza virus mRNA vaccine as an immunologic adjuvant for the first time, and the result shows that the prepared influenza virus mRNA vaccine can induce an organism to generate stronger body fluid and cellular immune response, and finally, the influenza virus infection can be effectively prevented. Therefore, when the MK-571 is used as the mRNA vaccine adjuvant, a new strategy is provided for development of influenza virus mRNA vaccines.

Подробнее
14-07-2010 дата публикации

Fowlpox virus vector shuttle plasmid and application thereof

Номер: CN0101775410A
Принадлежит:

The invention provides fowlpox virus vector shuttle plasmid pTGP3 which comprises recombinant arms TKL and TKR, a bidirectional promoter PE/L, a fluorescent protein expression cassette, and a resistant marker gene and replication origin ori; the upstream and the downstream of the bidirectional promoter PE/L are respectively provided with cloning sites MCSL and MCSR; and both ends of the fluorescent protein expression cassette are provided with loxp sequences. The plasmid of the invention has two different screening markers, and the recombinant fowlpox virus prepared with the plasmid can express 1 to 3 types of gene with different meshes in the whole processes of the early and the later periods; the strong composite promoter with expression activity in the early and the later periods is applied so as to realize the all-process high-efficiency expression of a target gene; and the loxp sequences are introduced into both ends of the fluorescent protein expression cassette, so as to knock out ...

Подробнее
16-01-2008 дата публикации

Preparation for antiviral protein CV-N

Номер: CN0101104851A
Принадлежит:

The invention is a method to prepare CVN antivirus protein, belonging to the biotechnology field. The invention aims at preparing CVN antivirus protein through gene mutation and recombination of the CVN in use. The invention is mainly characterized in that the 30bit asparagines-N,ACC is mutated to alanine-A,GCA, the glycosylation sites are wipe off, meanwhile the 51bit praline-P,CCG is mutated to glycin-G,GCA, and the gene sequence of synthetic CVN is constructed into prokaryotic expression vector pET28a. The invention has broad-spectrum antivirus activity and can be specifically combined with all the virus that have the same chain structure or the similar structure with high mannose oligosaccharide to neutralize the virus, blocking the infection and inhibiting the spread. The invention is expected to be developed into a new antivirus preparation to provide new thoughts and methods for the prevention and treatment of AIDS, AI, EV and the disease which has the glycoprotein structure.

Подробнее
21-07-2010 дата публикации

Recombined bacillus subtilis secretion type expression vector

Номер: CN0101781657A
Принадлежит:

The invention provides a recombined bacillus subtilis secretion type expression vector, which is constructed by inserting bacillus subtilis plasmid pGJ103 as a starting plasmid into an expression cassette with a bacillus subtilis promoter and a signal peptide sequence. The expression cassette comprises the bacillus subtilis promoter, the signal peptide sequence, a multiple-cloning-site sequence and a termination sequence which can be connected in an operative way. The expression vector pBC38C constructed in the invention can realize secretory expression of homologous genes and heterologous genes in bacillus subtilis, the expressed protein has good biological activity, and the parasitifer used by the expression vector is safe for animals and the environment and has bio-security. In addition, the expression vector has good genetic stability, and the recombined expression vector can not be lost after multiple passages and can continue carry out the secretory expression of foreign genes in ...

Подробнее
13-06-2012 дата публикации

Gene chip for detecting influenza A virus and preparation method and application thereof

Номер: CN0101701266B
Принадлежит:

The invention relates to a gene chip for typing influenza A virus, a preparation method thereof, a detection method and a detection kit, wherein the gene chip comprises a solid phase carrier and an oligonucleotide probe which is fixed on the solid phase carrier and contains DNA segments selected from one or more genes of HA, NA and/or M of the influenza A virus. The gene chip of the invention hasvery high sensitivity and specificity, can be used for simultaneously detecting a plurality of groups of influenza A virus genes and identifying groups by adopting a multiple PCR amplification mode, has wide application prospects, can identify the specific serotype, has efficient and quick detection and analysis methods, and can be applied to the fields of life science, medical testing, food safety, environmental surveillance, import and export inspection and quarantine, bioterrorism prevention, epidemiological surveillance, and the like.

Подробнее
18-06-2014 дата публикации

Primer combination for testing H7N9 subtype influenza virus and test kit

Номер: CN103866047A
Принадлежит:

The invention provides a primer combination for testing H7N9 subtype influenza virus and a test kit containing the same. The primer combination comprises a primer pair (Seq ID NO.1 and 2) for specifically amplifying an HA gene of the H7N9 subtype influenza virus and a primer pair (Seq ID NO.3 and 4) for specifically amplifying an NA gene of the H7N9 subtype influenza virus. The PCR (Polymerase Chain Reaction) primer pairs can be used for simultaneously performing amplification in a same PCR reaction tube so as to realize dual test; after optimization, rapid molecular identification of the HA gene and NA gene of the H7N9 subtype influenza virus can be finished within 5 hours, so the primer combination has the advantages of rapidness, simplicity, specificity, high sensitivity, low cost and stable results, and has a great significance in aspects of early warning, pathogen monitoring of an infected area and the like of epidemic situation of the H7N7 bird flu.

Подробнее
20-10-2010 дата публикации

Double-specificity anti-tumor recombinant adenovirus and construction method and application thereof

Номер: CN0101864452A
Принадлежит:

The invention provides a double-specificity anti-tumor recombinant adenovirus. The recombinant adenovirus comprises an adenovirus vector and expression boxes introduced therein; the replication of the adenovirus vector depends on gene mutation; and the expression boxes comprise an expression box consisting of tumor specific promoters and E1a genes and an expression box consisting of eukaryotic promoters and Apoptin genes. The invention also provides a construction mode of the double-specificity anti-tumor recombinant adenovirus and tumor treatment medicament application thereof. The recombinant adenovirus of the invention has double specificities of tumor specific replication and tumor specific killing, can be used for preparing medicaments for treating various tumors and medicaments for preventing tumor recurrence after operation, and meanwhile can be used with any medicament or used as a medicament combined with surgical therapy, radiotherapy and chemotherapy.

Подробнее
20-01-2010 дата публикации

Influenza compound multi-epitope DNA vaccine and application thereof

Номер: CN0101628118A
Принадлежит:

The invention relates to influenza compound multi-epitope genes and a DNA vaccine constructed by utilizing the influenza compound multi-epitope genes. The invention adopts the method of bioinformatics, combines a network server and relevant software, forecasts HA and NA functional epitopes which are related to major protective antigens of influenza and totally obtains 17 influenza CTL epitopes from a variety of subtypes and 12 influenza Th and B cell epitopes from a plurality of subtypes. Endoplasmic reticulum (ER) guiding signals are both added in the design of two epitope boxes, thereby promoting more efficient synthesis and folding of epitope peptide. The invention further dopes a plurality of general helper T cell epitopes (HTL) in the epitope boxes in the design. The DNA vaccine constructed by the influenza multi-epitope genes can simultaneously prevent a plurality of subtype influenza virus and carry out immune protection on a variety of types of animals.

Подробнее
30-09-2015 дата публикации

Recombinant oncolytic adenovirus and applications thereof

Номер: CN104946601A
Принадлежит:

The present invention provides novel recombinant oncolytic adenovirus and applications thereof. According to the present invention, the recombinant oncolytic adenovirus has double specificity of tumor-specific replication and tumor-specific killing, can be specifically replicated in tumor cells, and expresses apoptin gene having special tumor cell killing ability so as to improve the safety through enhancement of the tumor specificity; and with the replication of the recombinant oncolytic adenovirus and the killing ability of the apoptin gene, the tumor killing ability is improved.

Подробнее
18-11-2009 дата публикации

HIV composite multi-epitope DNA vaccine and application thereof

Номер: CN0101579528A
Принадлежит:

The invention discloses an HIV composite multi-epitope DNA vaccine which takes HIV-1 capsid protein p24 as a vector backbone molecule and ER signal peptide as a homing sequence, and contains twenty-six highly conservative immunodominant epitopes in an HIV genome; wherein, the HIV composite multi-epitope DNA vaccine comprises twenty-nine epitopes which are three neutralizing antibody epitopes, twenty-three CTL epitopes, one HIV-1 isolate common antibody epitope, one MHC nonrestrictive T helper lymphocyte epitope and one spasmotoxin B cell epitope. The vaccine can be used for vaccination of healthy people and immunization therapy of people who are infected by AIDS virus, thus having double effects of prevention and treatment.

Подробнее
16-11-2011 дата публикации

Fowlpox virus vector shuttle plasmid and application thereof

Номер: CN0101775410B
Принадлежит:

The invention provides fowlpox virus vector shuttle plasmid pTGP3 which comprises recombinant arms TKL and TKR, a bidirectional promoter PE/L, a fluorescent protein expression cassette, and a resistant marker gene and replication origin ori; the upstream and the downstream of the bidirectional promoter PE/L are respectively provided with cloning sites MCSL and MCSR; and both ends of the fluorescent protein expression cassette are provided with loxp sequences. The plasmid of the invention has two different screening markers, and the recombinant fowlpox virus prepared with the plasmid can express 1 to 3 types of gene with different meshes in the whole processes of the early and the later periods; the strong composite promoter with expression activity in the early and the later periods is applied so as to realize the all-process high-efficiency expression of a target gene; and the loxp sequences are introduced into both ends of the fluorescent protein expression cassette, so as to knock out ...

Подробнее
22-09-2010 дата публикации

Asia 1-type FMDV compound multiepitope

Номер: CN0101838319A
Принадлежит:

The invention provides an Asia 1-type FMDV compound multiepitope which adopts an Asia 1-type FMDV capsid protein VP1 antigen activity area as the basic skeleton, and comprises the epitope of Asia 1/JL/05 plant VP1, the epitope of the IND 63/72 plant VP1, the epitope of YNBS/58 plant VP1, cholera toxin B subunit and helper T lymphocyte epitope. The compound multiepitope can be used for preparing Asia 1-type FMDV subunit vaccine, nucleic acid vaccine, synthetic peptide vaccine, live vector vaccine and a plurality of genetic engineering vaccines.

Подробнее